V Bisacodyl (Dulcolax)

V Metoclopramide (Plasil)
V Nalbuphine (Nubain)
V Mefenamic Acid (Dolfenal)
V Cefazolin (Fonvicol)
V Ranitidine (Zantac)
V Constipation.

V Preparation for barium enema.

V Pre and post operative.

V Oncreases peristalsis and motor activity of
the small intestines by acting directly on
the smooth muscles.
V May stimulate the colonic intramural
plexus, and promote fluid accumulation
in the intestines and colon.
V stomach ache, V Occasional
V cramping abdominal
V weakness discomfort,
V sweating, V Soreness in the anal
region.
V irritation of the rectal
area,
V diarrhea
V dizziness
V Nausea
V vomiting, or other symptoms of
appendicitis;
V Acute surgical abdomen
V fecal impaction
V intestinal obstruction.
V Monitor frequency and character of
stools.
V Monitor occurrence of adverse reactions
(abdominal cramps, nausea, vomiting,
fluid and electrolyte imbalanced, muscle
weakness).
V Assess abdominal pain, nausea and
vomiting.

V Teach the patient about dietary sources

of fiber (bran, cereals, fruits and
vegetable)
V Discuss with the patient adequate fluid,
bulk consumption and exercise facilities
bowel movement.
V Warn the patient of the excessive use of
drug
V —
  
V
V PPd·s Nursing Drug guide 2nd edition for
nursing students and professional nurses
published for MALAN PRESS ONC. p.476
V PPD 13th annual edition 2006-2007 p.294
Classification Dosage Timing

‡ CNS Drug ‡ (1 ampule) ‡ Every 6

10mg/2ml hours 0000,
0600, 1200,
1800

‡ (O Push)
V To control post operative vomiting.
V Dopamine antagonist that acts by
increasing receptor sensitivity and response
of upper GOT tissues to acetylcholine.
V This causes contraction of gastric smooth
muscle, relaxation of the pyloric sphincter
and duodenal bulb.
V Oncreased peristalsis without gastric, biliary
and pancreatic secretions.
V Ot also produces sedation and induces the
release of prolactin.
V Restlessness V Somnolence
V Drowsiness V Nervousness
V Fatigue V dystonic reactions.
V Onsomnia V Oncreased pituitary
V Headache prolactin release
V Dizziness and menstrual
discharge.
V Nausea
V Bowel Disturbance
V Phaeochromocytoma.

V Patients in who increased GO motility might

be dangerous e.g. presence of GO
hemorrhage mechanical obstruction or
perforation.

V Hypersensitivity or intolerance to drug.

V Lactation.
V Assess patient·s GO complaints: nausea,
vomiting, anorexia, constipation,
abdominal distention before and after
administration.

V Frequent monitor blood pressure of

patients taking O form of drug.

V Monitor for possible drug induced

adverse reactions.

V Assess mental status during treatment:

depression, anxiety and irritability.
V Assess patient·s and family·s knowledge
of drug therapy
V —
  
V PPd·s Nursing Drug guide 2nd edition for
nursing students and professional nurses
published for MALAN PRESS ONC. p.490

V PPD 13th annual edition 2006-2007 p. 296

Classification Dosage Timing

‡ CNS Drug ‡ (1 ampule) ‡ Every 6

hours 0000,
0600, 1200,
1800

‡ (O Push)
V Relief of moderate pain; for pre-
operatively analgesia.

V Supplement to balanced anesthesia.

V Obstetrical analgesia
V Binds with opiate receptors in the CNS:
ascending pain pathways in limbic
system, thalamus, midbrain,
hypothalamus, altering perception of
and emotional response to pain.
V And it relieves pain
V Sedation V Allergic reactions like
V Drowsiness rashes.
V Sweating
V Dryness of mouth
V Nausea and
omiting
V Headac
V Hypersensitivity.
V Assess patient·s and Family·s knowledge
of drug therapy.
V Asses pain characteristics (location,
intensity, type) before administration and
after treatment,
V Monitor vital signs after parenteral route..

V Monitor respiratory depression; assess

respiratory rate, character and rhythm.
Report respiratory if <10/min. watch out
for muscle rigidity.
V Monitor allergic reaction: rash, pruritis,
and urticaria.
V Monitor for possible adverse drug
reactions
V —
  

V PPd·s Nursing Drug guide 2nd edition for

nursing students and professional nurses
published for MALAN PRESS ONC. p.27
V PPD 13th annual edition 2006-2007 p. 17
Classification Dosage Timing

‡ NSAODs ‡ 500mg/tab ‡ Every 6

(1 Tablet) hours 0000,
0600, 1200,
1800

‡ (O Push)
V Relief of pain including post-operative
and headache and fever
V Aspirin-like drug that has analgesic,
antipyretic and anti-inflammatory, activities.

V These activities appear to be due to its

ability to inhibit cyclooxygenase and also
antagonize certain effects of
prostaglandins.

V Ot displays central and peripheral activities.

V GO disturbances V isual disturbances
V GO hemorrhage V asthma
V Drowsiness V urticaria
V Dizziness
V Headache
V isual Disturbances
V Pregnancy and lactation.

V Hypersensitivity.

V Of diarrhea and skin rash appears, the

drug should stop at once.

V History of kidney or liver disease.

V Advice the patient not to over dose the
drug.

V Advice the patient to immediately report

persistence or failure to relieve pain.

V Do health teachings about the adverse

reaction of drug.

V Onstruct the patient to report the drug

induced adverse reactions.
V —
  

V PPd·s Nursing Drug guide 2nd edition for

nursing students and professional nurses
published for MALAN PRESS ONC. p.27
V PPD 13th annual edition 2006-2007 p. 17
Classification Dosage Timing

‡ Anti- ‡ 1g/10ml ‡ 20 hours

infectives prior to
procedure

‡ (O Push)
V Post operative wound and trauma.

V Gynecological infections.
V Onhibits bacterial cell wall synthesis thus
promoting osmotic instability which
eventually leads to bacterial cell death.
V Signs of allergy: skin V Oral thrush
rash and fever. V Shock
V Nausea and V itamin B group
omiting. deficiencies.
V Diarrhea
V Allergy to penicillin and cephalosporin.
V Asses patient·s previous sensitivity
reaction to penicillin and cephalosporin

V Assess patient for signs and symptoms of

infection before and during infection:
fever, ear ache, characteristics of
wounds, sputum, urine, stool, and WBC
count.

V Assess for anaphylactic reaction.

V Renal function and possible super

infection.
V —
  

V PPd·s Nursing Drug guide 2nd edition for

nursing students and professional nurses
published for MALAN PRESS ONC. p. 494
V PPD 13th annual edition 2006-2007 p. 291
 Classification Dosage Timing

‡ 500 mg ‡ Every 12 hours

‡ Gastrointestinal (while on drip) 0000, 1200
Drugs
‡ (O Push)
V Prophylaxis of GO hemorrhage from stress
ulceration.
V Onhibits histamine at H2 receptor site in
the gastric parietal cells, which inhibits
gastric acid secretion.
V Nausea and V Bradychardia
omiting V Depression
V Abdominal V Onsomnia
discomforts V Alopecia
V Headache
V Fatigue
V Dizziness
V Diarrhea
V Hypersensitivity.
V ‰sed caution in presence of renal or
hepatic impairment.

V Assess potential for interactions with other

pharmacological agents patients maybe
taking (E.G., increase or decrease effects
of toxicity).

V Evaluate results of laboratory test

therapeutic effect and adverse reactions.

V Assess knowledge/ teach patient

appropriate use, possible side
effects/appropriate interventions, and
adverse symptoms to report.
V —
  

V PPD·s Nursing Drug guide 2nd edition for

nursing students and professional nurses
published for MALAN PRESS ONC. p. 494
V PPD 13th annual edition 2006-2007 p. 291